Portfolio Companies
The Go Red for Women Venture Fund portfolio companies are making meaningful, measurable advancements in heart, brain and related conditions that affect women differently, disproportionately or distinctively. See how investment in innovation is sparking real-world change.
Ìý
Interested in exploring investment opportunities?
We’d love to hear how you’re transforming health for women
Aurenar aims to redefine stroke recovery with a novel, non-invasive technology targeting neuroinflammation. Its V-Link device is designed to reduce life-threatening complications and long-term neurological impact for stroke patients in the ICU. V-Link’s initial focus will be patients with subarachnoid hemorrhage, a stroke that disproportionately affects women.
Neura Health is a virtual neurology clinic leveraging advanced data analytics and AI-powered diagnostics to accelerate early detection and deliver personalized treatment and monitoring of neurological conditions. Many of these, including migraine and dementia, disproportionately affect women and often present differently, underscoring the need for tailored, tech-enabled care.
Ultromics, a pioneer in AI-driven cardiology solutions, has built the first and only FDA-cleared, AI diagnostic-support tool for identifying Heart Failure with preserved Ejection Fraction (HFpEF) and its underlying cause, cardiac amyloidosis, earlier and more precisely. These are two of the most elusive forms of heart failure, and they disproportionately affect women.
Get on the list!
Be the first to know about 91ÊÓÆµ Ventures news, events and opportunities.